Moving from Development to Testing

Exploring the synergy of technology and human senses with vibration.

Cerabellah has successfully completed the intricate development of a comprehensive baseline design for their innovative device, which has now progressed to the manufacturing stage where test units are being produced. These test units have undergone rigorous trials aimed at evaluating both safety and effectiveness, ensuring that the device meets the highest standards before it reaches a wider audience. To gather meaningful data, a carefully structured survey was conducted involving a diverse group of participants ranging in age from 16 to 96 years. This broad age range was intentional, as it allowed for a more comprehensive understanding of the device's impact across different demographics.

During the trials, the device applied vibrations at two specific frequencies, either 20 or 40 Hertz, for a duration of 10 minutes. This controlled exposure was designed to assess the physiological and psychological responses of the users. Remarkably, throughout the study, no adverse physical or mental health effects were reported, indicating a strong safety profile for the device. Participants were closely monitored over a period of one month following their use of the device, and throughout this time, there were no adverse reports, further reinforcing the device's safety credentials.

In addition to safety, the subjective experiences of the users were taken into account, with the majority of participants reporting a noticeable increase in their overall sense of wellbeing. This feedback is crucial, as it not only highlights the potential benefits of the device but also emphasizes the importance of user experience in the development process. The initial screening survey played a pivotal role in the research, enabling the creation of a more refined survey tool that can be utilized for further screening and evaluation in future studies.

Interestingly, several individuals chose to use the device for extended periods, engaging with it for an hour multiple times a week, and they did so without experiencing any adverse effects. This level of engagement suggests that users are finding the device beneficial and are willing to incorporate it into their regular routines. The promising results from these trials significantly advance Cerabellah's overarching goal of ensuring safety, demonstrating effectiveness, and ultimately making the device publicly available for those who could benefit from it. The ongoing commitment to rigorous testing and user feedback will continue to shape the development of this innovative technology, paving the way for its successful introduction into the market.